Colony-stimulating factor-1 (CSF-1) is able promote the function and survival of small glioma cells and TAMs, and the inhibition of the CSF-1 receptor (CSF-1R) relieves TME immunosuppression by depleting TAMs and synergizes with other immunotherapies (34). Here, CSF1R is linked to central nervous system cancer.